Brief: Point72 Asset Management, L.P Reports 5.6% Passive Stake In Vistagen Therapeutics, Inc. As Of October 4- SEC Filing
05/10/2023 21:53
Oct 5 (Reuters) - VistaGen Therapeutics Inc VTGN.O :
* POINT72 ASSET MANAGEMENT, L.P REPORTS 5.6% PASSIVE STAKE
IN
VISTAGEN THERAPEUTICS, INC. AS OF OCTOBER 4- SEC FILING
Further company coverage: VTGN.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors